Loblaw Companies Limited — the price of durable grocery margins

Our maximum entry price is C$33.36 per share. Loblaw (TSX: L, Consumer Staples) closed at C$70.92 on November 19, 2026, so we would wait. Pharmacy is growing, but at our base discount rate the price requires an enduring improvement in retail cash margins. Using the last year of observed market risk raises the entry to C$90.29 and flips the decision; the three-year estimate gives C$66.79 and still says wait. Loblaw TSX daily closing prices

Stock Price History

Market close (CAD)
70.92
Base fair value (CAD/share)
37.89
Company details
Maximum entry price (CAD/share)
33.36

Stock Price History

Investment Thesis

Food and pharmacy provide repeat demand while store openings add volume. The crucial investment question is how much of the resulting profit survives rent and store reinvestment. Q3 sales by category and comparable store sales, p. 12 · Highlighted Peralta exhibit Management outlook and gross capital expenditure, p. 28

Market Mispricing

The close implies a sustained 14.86% pre-rent EBITDA margin with our other assumptions fixed. Our 11.2% base is close to the reported Q3 adjusted EBITDA margin of 11.3%. A lower required return or stronger growth could also explain the price. Operating performance and adjusted EBITDA margin, p. 8

Recent Developments

The July PC Financial disposal leaves an equity investment and a loyalty partnership. Continuing retail operations no longer earn the disposed bank’s revenue. Note 9, EQB and other investments, p. 58 Note 4, discontinued earnings and sale gain, p. 54 · Highlighted Peralta exhibit

Earnings Outlook

The issuer expects high-single-digit adjusted EPS growth for 2026. Share repurchases help EPS even when earnings grow more slowly. We value the operating business before assuming future share retirement. Management outlook and gross capital expenditure, p. 28 Note 11, common-share movements, p. 60

Valuation Summary

Ten forward years plus terminal cash flows give C$37.89 per diluted share. A perpetual half-point shortfall in EBITDA margin reduces value to C$33.37 before conservative cent rounding. Calculation

Recommended Action and Entry Price

Wait. The stressed operating value limits entry to C$33.36; the separate five-year return hurdle allows C$33.82. This width is a model conclusion worth challenging against peer prices.

Catalysts

At the next quarterly filing, compare food traffic, pharmacy same-store sales, and capex with the opening of new stores. Volume recovery at stable margins would strengthen the case. Q3 sales by category and comparable store sales, p. 12 · Highlighted Peralta exhibit Management outlook and gross capital expenditure, p. 28

Primary Risks to Thesis

The largest upside risk to a wait decision is a structurally lower required return combined with better cash conversion. A 100 bp lower discount rate alone raises fair value to C$48.81.